semaglutide bowel obstruction class action in dallas lawyer Millions of patients turned to Ozempic, Wegovy, and other GLP-1 Ozempic Lawsuit | Latest Litigation

As clinical data and public discussion intersect, these launches are rewriting every rule in pharma marketing commanding broad consumer attention, setting new standards for adoption speed, and (perhaps most importantly) reshaping eXpectations around how life sciences brands engage, educate, and []

Non-variceal upper gastrointestinal bleeding (NVUGIB) accounts for a significant number of patient visits to emergency rooms and remains a major cause of mortality and morbidity worldwide

In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)

Since tirzepatide is a dual GLP1R/GIPR agonist, the interpretation is compelling: GIP receptor activation normally buffers the nausea-inducing effects of GLP-1 agonism, and when that buffer is genetically impaired, the GLP-1 component goes unchecked

Half of adults who start semaglutide for weight loss discontinue within a year, according to a study presented at the annual meeting of the European Association